GLP-1 and Inflammation — The Anti-Aging Connection

Join Dr. Ben Synth as he explores the groundbreaking science behind GLP-1 medications and their unexpected role in fighting chronic inflammation—the silent driver of aging, heart disease, dementia, and cancer. Discover why these drugs may be far more than just weight loss tools, with profound implications for longevity.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.

Ben Synth explores how GLP-1 drugs like Ozempic may revolutionize disease prevention beyond weight loss. A Nature Medicine study of nearly one million diabetes patients revealed 10-20% reductions in Alzheimer's, heart failure, and lung disease—suggesting these medications combat chronic inflammation driving aging itself, potentially rewriting our understanding of interconnected human diseases.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.

Ben Synth explores groundbreaking research suggesting GLP-1 drugs like semaglutide may reverse biological aging beyond weight loss. From mouse studies showing rejuvenation across seven organ systems to human trials demonstrating slowed epigenetic clocks, he examines the compelling but incomplete evidence that these medications might actually turn back our molecular clocks through anti-inflammatory mechanisms targeting the hallmarks of aging.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.

Join AI host Ben Synth as he explores how GLP-1 drugs like Ozempic may combat chronic inflammation, a key driver of aging. Drawing on 2025 research including Nature Medicine studies of nearly a million patients, Ben examines mechanisms like NF-kB suppression and epigenetic clock slowing that suggest these medications do far more than promote weight loss.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.